Medication info
Telmisartan 40 mg Tablet

Telmisartan 40 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
White or whitish oval-shaped tablets
Packaging
30 tablets/box [(10 tablets/Alu-Alu x 3)]
Approval status
Active

MFDS item code 201006076 · Notified 2010.10.08 · Insurance code 640005970

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular events (e.g., myocardial infarction and stroke)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. This medication produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medication be administered orally at 80 mg once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medication to reduce cardiovascular risk, monitoring of blood pressure is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular events (e.g., myocardial infarction and stroke)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attacks
  • clinical evidence of high-risk diabetes with end-organ damage
  • myocardial infarction
View approved original text

This medication provides blood pressure control effects for patients with essential hypertension. Additionally, it helps lower the risk of developing cardiovascular disease in high-risk patients aged 55 and older who cannot use ACE inhibitors, reducing the risk of myocardial infarction, stroke, and death from cardiovascular diseases. It is particularly useful for patients with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attacks, or diabetic end-organ damage. This medication is effective in stabilizing blood pressure and protecting cardiovascular health.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. This medication produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medication be administered orally at 80 mg once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medication to reduce cardiovascular risk, monitoring of blood pressure is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Women who are pregnant or may become pregnant, and nursing mothers should not use this medication. Patients with severely impaired liver function or problems with bile secretion should avoid this medication. Individuals with an allergy to this medication or its components should refrain from taking it. Patients with a history of angioedema or who are taking ACE inhibitors or similar medications and have experienced angioedema should be cautious. In diabetic patients with moderate or higher renal impairment, co-administration with specific medications is prohibited. Elderly patients, those with hyperkalemia, and patients with mildly impaired liver function should use this medication carefully. Patients with valvular heart disease or ischemic heart disease, or cerebrovascular disorders should be cautious of excessively low blood pressure. Patients with gastrointestinal diseases may experience more frequent gastrointestinal bleeding or discomfort while taking this medication, so caution is necessary. Patients with renal vascular problems may face risks of worsening renal function, requiring special attention. It is essential to regularly monitor blood pressure, kidney function, and serum potassium levels during treatment to ensure no abnormalities. Due to the strong antihypertensive effect, symptoms of hypotension, dizziness, or syncope should be reported immediately to healthcare professionals. This medication may interact with certain drugs, so inform your healthcare provider about any medications you are currently taking. Particular caution is required when combined with other antihypertensive medications, lithium, diuretics, or non-steroidal anti-inflammatory medications. In case of overdose, hypotension, cardiac arrhythmias, or acute renal failure may occur, requiring emergency treatment. Safety in children and adolescents under 18 years has not been established, and use is not recommended. This medication contains sorbitol, making it unsuitable for patients with certain sugar intolerances. Caution is advised when driving or operating hazardous machinery while on this medication. Store out of reach of children, avoid moisture, and the tablets should be taken out of their packaging just before use.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 82 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbance
  • liver function abnormality
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • facial twitching
  • sensory disturbance
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • decreased appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • palpitations
  • nausea
  • insufficient effect
  • arrhythmia
  • angioedema
  • shock
  • loss of consciousness
  • jaundice
  • anaphylaxis-like symptoms
  • interstitial pneumonia
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius to safely maintain the medication's efficacy.

Appearance and packaging

Appearance

White or whitish oval-shaped tablets

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.